Account
Insider Insights
01.11.2022
A winter of discontent? European pharmaceutical so...

EUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t...

Read more
Articles
22.06.2022
EU Joint HTA: How should manufacturers adapt to th...

EUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...

Read more
Articles
21.06.2022
Seeking early advice from the EMA and multiple HTA...

Introduction Achieving access to patients for innovative treatments is becoming a significant challe...

Read more
Articles
07.06.2022
EU Joint HTA: What’s going on and what does it m...

EUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...

Read more
Articles
07.12.2021
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
03.12.2021
Reflecting on the Pricing & Market Access tren...

Our experts reflect on the pricing and market access trends that shaped the European Landscape in 20...

Read more
Articles
12.07.2021
EU & UK Reference Pricing Guide

The EU is known for the variety of market access rules its member states impose. We’re here to gui...

Read more
Articles
25.06.2021
EU Joint HTA Process Finally Agreed

The European Parliament and Council negotiators reached a provisional agreement on a joint health te...

Read more
Articles
02.06.2021
EU Joint HTA EESC publish its positive option

Are we one step closer to an EU Health Technology Assessment body. The EESC publish its positive opi...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.